Skip to main content

Table 2 Comparative clinical trial data with ASAQ Winthrop (as of December 2010)

From: Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience

Comparator drug Country, Reference Patients Patients receiving ASAQ Winthrop
Non-fixed combination of aretsunate + amodiaquine Burkina Faso [5] Children < 5 years 375
Amodiaquine India [SP] Children and adults 201
Artemether-lumefantrine Senegal, Mali, Cameroon, Madagascar [8] Children and adults 629
  Benin [13] Children < 10 years 90
  Liberia [14] Children < 5 years 150
  Liberia [15] Children and adults 496
  Senegal [16] Children and adults 184
  Colombia [SP] Adults 105
  Uganda [SP] Children < 5 years 200
Artemether-lumefantrine and DHA-piperaquine Burkina Faso, Gabon, Mozambique, Nigeria, Rwanda, Uganda, Zambia [17]   1002
Total    3432
  1. [SP] Submitted for publication